KLF15 antibody

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
KLF15 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab04600
tested applications
ELISA, WB

Description

Transcriptional regulator that binds to the GA element of the CLCNKA promoter. Binds to the KCNIP2 promoter and regulates KCNIP2 circadian expression in the heart(By similarity). Is a repressor of CTGF expression, involved in the control of cardiac fibrosis. It is also involved in the control of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4(By similarity). Involved in podocyte differentiation(By similarity). Inhibits MYOCD activity. Is a negative regulator of TP53 acetylation. Inhibits NF-kappa-B activation through repression of EP300-dependent RELA acetylation.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Kruppel-like factor 15 (KLF15)
Host
Mouse
Reactivity
Human
Recommended Dilution
WB: 1:500 - 1:2000
Clonality
monoclonal
Conjugation
Unconjugated
Isotype
IgG2a
Clone ID
1C10
Observed MW
45 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Protein A+G purification
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q9UIH9
Gene ID
28999
Alias
Krueppel-like factor 15,Kidney-enriched krueppel-like factor,KLF15,KKLF
Background
Antibody anti-KLF15
Status
RUO
Note
Mol. Weight 45 kDa

Descripción

Related Products

EH9646

Human KLF15 (Krueppel-like factor 15) ELISA Kit

Ver Producto
FNab04600

KLF15 antibody

Transcriptional regulator that binds to the GA element of the CLCNKA promoter. Binds to the KCNIP2 promoter and regulates KCNIP2 circadian expression in the heart(By similarity). Is a repressor of CTGF expression, involved in the control of cardiac fibrosis. It is also involved in the control of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4(By similarity). Involved in podocyte differentiation(By similarity). Inhibits MYOCD activity. Is a negative regulator of TP53 acetylation. Inhibits NF-kappa-B activation through repression of EP300-dependent RELA acetylation.

Ver Producto
abx005428

Krueppel-Like Factor 15 (KLF15) Antibody

KLF15 Antibody is a Rabbit Polyclonal antibody against KLF15.

Ver Producto